Financial statements Wytwórnia Surowic I Szczepionek Biomed
Cash flow statement of Wytwórnia Surowic I Szczepionek Biomed
Company age:
Age:
18 y. 3 m. 21 d.
Share capital:
Share capital:
9 000 000 PLN
Cash inflows of WYTWÓRNIA SUROWIC I SZCZEPIONEK BIOMED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 1 344 128,21 | -141 722,02 | 754 900,97 | 1 917 595,07 | 3 097 296,46 | 1 398 307,84 |
| Net cash flow from investing activities | -327 277,22 | -235 094,01 | -155 166,24 | -972 687,11 | -1 087 934,77 | -1 104 320,98 |
| Net cash flow from financial activities | -1 187 535,47 | 1 598 967,25 | -1 395 694,90 | -1 168 288,67 | -988 407,53 | -955 178,05 |
| Total net cash flow | -170 684,48 | 1 222 151,22 | -795 960,17 | -223 380,71 | 1 020 954,16 | -661 191,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.